Intervention of Interest
- brensocatib (Insmed Pharmaceuticals)
For questions please contact info@icer.org.
View the Key Stakeholder List.
Non-Cystic Fibrosis Bronchiectasis
An assessment of brensocatib
Public Meeting
September 2025
Assessment Status
Open
Upcoming Milestone
Revised Scoping DocumentView
Main Review
September 25, 2025
CTAF
The CTAF’s 2025 public meeting on brensocatib
Public Comment Period
See Full Timeline
03/11/2025 - 03/31/2025
Public Comments on Draft Scoping Document
Related Assessments & Policy Papers.
Cystic Fibrosis
Aug 2020Cystic Fibrosis
May 2018
04/09/2025
Revised Scoping Document
04/16/2025
Research Protocol
Please find the research protocol here:
06/06/2025
Model Analysis Plan
09/08/2025
Evidence Report
09/25/2025
Evidence Presentation
10/27/2025
Public Comments
OpenView
Closed